Literature DB >> 19171867

Antihypertensive efficacy of aliskiren: is hydrochlorothiazide an appropriate benchmark?

Franz H Messerli, Sripal Bangalore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19171867     DOI： 10.1161/CIRCULATIONAHA.108.828897

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  Update in new medications for primary care.

Authors:  Gerald W Smetana; Jane S Sillman
Journal:  J Gen Intern Med       Date:  2009-12-12       Impact factor: 5.128

2.  Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.

Authors:  Mark A Peterzan; Rebecca Hardy; Nish Chaturvedi; Alun D Hughes
Journal:  Hypertension       Date:  2012-04-30       Impact factor: 10.190

Review 3.  β-Adrenergic blockers.

Authors:  William H Frishman; Elijah Saunders
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-08-08       Impact factor: 3.738

4.  Why are we still using hydrochlorothiazide?

Authors:  Clive Rosendorff
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-12-01       Impact factor: 3.738

Review 5.  Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials.

Authors:  Sripal Bangalore; Sunil Kumar; Jørn Wetterslev; Franz H Messerli
Journal:  BMJ       Date:  2011-04-26

Review 6.  Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!

Authors:  Giuseppe Maiolino; Matteo Azzolini; Gian Paolo Rossi
Journal:  Front Cardiovasc Med       Date:  2015-02-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.